☆Ishara Investments LP
Quality Q
0.018
AUM ($M)
136
Positions
41
Turnover
0.47
Top-10 wt
51%
Herfindahl
0.039
History (qtrs)
3
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 52 positions · portfolio value $136M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆ACAD funds › | ACADIA PHARMACEUTICALS INC | ADD | — | 7.6% | +4.9% | 10.4 | 410,000 | +287,000 | 2 | — |
| ☆XERS funds › | XERIS BIOPHARMA HOLDINGS INC | ADD | — | 7.2% | +1.2% | 9.7 | 1,230,000 | +205,000 | 2 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | ADD | — | 6.0% | +1.4% | 8.2 | 143,500 | +61,500 | 2 | — |
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | HOLD | — | 5.5% | -1.8% | 7.5 | 22,550 | +0 | 2 | — |
| ☆RARE funds › | ULTRAGENYX PHARMACEUTICAL IN | ADD | — | 5.0% | +1.3% | 6.8 | 205,000 | +30,750 | 2 | — |
| ☆AGIO funds › | AGIOS PHARMACEUTICALS INC | NEW | — | 4.5% | +4.5% | 6.1 | 164,000 | +164,000 | 1 | — |
| ☆INSM funds › | INSMED INC | NEW | — | 4.0% | +4.0% | 5.5 | 51,250 | +51,250 | 1 | — |
| ☆CRNX funds › | CRINETICS PHARMACEUTICALS IN | NEW | — | 3.9% | +3.9% | 5.4 | 143,500 | +143,500 | 1 | — |
| ☆ZNTL funds › | ZENTALIS PHARMACEUTICALS INC | TRIM | — | 3.7% | +0.7% | 5.0 | 1,025,000 | -205,000 | 2 | — |
| ☆PCVX funds › | VAXCYTE INC | ADD | — | 3.5% | +0.1% | 4.8 | 82,000 | +24,600 | 2 | — |
| ☆ANNX funds › | ANNEXON INC | ADD | — | 3.4% | +2.5% | 4.7 | 820,000 | +645,750 | 2 | — |
| ☆TVTX funds › | TRAVERE THERAPEUTICS INC | TRIM | — | 3.4% | +0.1% | 4.7 | 82,000 | -28,700 | 2 | — |
| ☆TNXP funds › | TONIX PHARMACEUTICALS HLDG C | NEW | — | 3.2% | +3.2% | 4.3 | 338,250 | +338,250 | 1 | — |
| ☆BBIO funds › | BRIDGEBIO PHARMA INC | NEW | — | 3.1% | +3.1% | 4.3 | 57,400 | +57,400 | 1 | — |
| ☆AXSM funds › | AXSOME THERAPEUTICS INC. | TRIM | — | 2.9% | -4.0% | 4.0 | 16,400 | -24,600 | 2 | — |
| ☆CTNM funds › | CONTINEUM THERAPEUTICS INC | ADD | — | 2.5% | +0.6% | 3.4 | 205,000 | +63,000 | 2 | — |
| ☆LXRX funds › | LEXICON PHARMACEUTICALS INC | ADD | — | 2.2% | +0.8% | 3.1 | 1,271,000 | +369,000 | 2 | — |
| ☆KURA funds › | KURA ONCOLOGY INC | NEW | — | 2.2% | +2.2% | 3.0 | 276,750 | +276,750 | 1 | — |
| ☆DBVT funds › | DBV TECHNOLOGIES S A | ADD | — | 2.2% | +0.1% | 3.0 | 184,500 | +82,000 | 2 | — |
| ☆GMAB funds › | GENMAB A/S | ADD | — | 2.1% | -0.2% | 2.8 | 102,500 | +20,500 | 2 | — |
| ☆CYTK funds › | CYTOKINETICS INC | NEW | — | 2.1% | +2.1% | 2.8 | 32,800 | +32,800 | 1 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | ADD | — | 2.0% | -0.2% | 2.8 | 102,500 | +20,500 | 2 | — |
| ☆SLN funds › | SILENCE THERAPEUTICS PLC | TRIM | — | 1.8% | +1.0% | 2.4 | 55,350 | -85,150 | 2 | — |
| ☆NUVB funds › | NUVATION BIO INC | NEW | — | 1.5% | +1.5% | 2.1 | 369,000 | +369,000 | 1 | — |
| ☆WVE funds › | WAVE LIFE SCIENCES LTD | NEW | — | 1.4% | +1.4% | 1.9 | 328,000 | +328,000 | 1 | — |
| ☆NKTR funds › | NEKTAR THERAPEUTICS | NEW | — | 1.4% | +1.4% | 1.9 | 26,650 | +26,650 | 1 | — |
| ☆SRRK funds › | SCHOLAR ROCK HLDG CORP | TRIM | — | 1.2% | -1.6% | 1.7 | 30,750 | -26,650 | 2 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | NEW | — | 1.2% | +1.2% | 1.7 | 32,800 | +32,800 | 1 | — |
| ☆ALNY funds › | ALNYLAM PHARMACEUTICALS INC | HOLD | — | 1.1% | -0.6% | 1.5 | 5,125 | +0 | 2 | — |
| ☆BEAM funds › | BEAM THERAPEUTICS INC | TRIM | — | 1.0% | -0.3% | 1.4 | 41,000 | -16,400 | 2 | — |
| ☆SION funds › | SIONNA THERAPEUTICS INC | ADD | — | 1.0% | -1.0% | 1.4 | 123,000 | +73,800 | 2 | — |
| ☆ORIC funds › | ORIC PHARMACEUTICALS INC | ADD | — | 1.0% | -0.3% | 1.3 | 123,000 | +20,500 | 2 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA COMPANY | HOLD | — | 0.9% | -0.3% | 1.3 | 36,900 | +0 | 2 | — |
| ☆VRTX funds › | VERTEX PHARMACEUTICALS INC | NEW | — | 0.9% | +0.9% | 1.2 | 2,460 | +2,460 | 1 | — |
| ☆SPRY funds › | ARS PHARMACEUTICALS INC | NEW | — | 0.8% | +0.8% | 1.1 | 143,490 | +143,490 | 1 | — |
| ☆MNPR funds › | MONOPAR THERAPEUTICS INC | NEW | — | 0.8% | +0.8% | 1.1 | 12,300 | +12,300 | 1 | — |
| ☆ERAS funds › | ERASCA INC | NEW | — | 0.6% | +0.6% | 0.8 | 41,000 | +41,000 | 1 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | TRIM | — | 0.3% | -3.0% | 0.4 | 10,250 | -71,750 | 2 | — |
| ☆IMTX funds › | IMMATICS N.V | TRIM | — | 0.2% | -1.3% | 0.3 | 30,750 | -123,000 | 2 | — |
| ☆MREO funds › | MEREO BIOPHARMA GROUP PLC | NEW | — | 0.2% | +0.2% | 0.2 | 768,750 | +768,750 | 1 | — |
| ☆GOSS funds › | GOSSAMER BIO INC | HOLD | — | 0.1% | -0.2% | 0.1 | 820,000 | +0 | 2 | — |
| ☆LGND funds › | LIGAND PHARMACEUTICALS INC | EXIT | — | 0.0% | -1.7% | 0.0 | 0 | -8,200 | 0 | — |
| ☆CUSIP:03152W109 funds › | AMICUS THERAPEUTIC | EXIT | — | 0.0% | -5.4% | 0.0 | 0 | -369,000 | 0 | — |
| ☆CUSIP:483497103 funds › | KALVISTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -5.6% | 0.0 | 0 | -276,750 | 0 | — |
| ☆PTCT funds › | PTC THERAPEUTICS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -10,250 | 0 | — |
| ☆ARWR funds › | ARROWHEAD PHARMACEUTICALS IN | EXIT | — | 0.0% | -3.5% | 0.0 | 0 | -55,350 | 0 | — |
| ☆IDYA funds › | IDEAYA BIOSCIENCES INC | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -24,600 | 0 | — |
| ☆VSTM funds › | VERASTEM INC | EXIT | — | 0.0% | -4.4% | 0.0 | 0 | -820,000 | 0 | — |
| ☆ARDX funds › | ARDELYX INC | EXIT | — | 0.0% | -2.7% | 0.0 | 0 | -451,000 | 0 | — |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | EXIT | — | 0.0% | -3.3% | 0.0 | 0 | -174,250 | 0 | — |
| ☆CPRX funds › | CATALYST PHARMACEUTICALS INC | EXIT | — | 0.0% | -2.1% | 0.0 | 0 | -82,000 | 0 | — |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | EXIT | — | 0.0% | -1.6% | 0.0 | 0 | -49,200 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 136 | 41 | 0.47 | 51% | 0.039 | 0.018 | — | in |
| 2026Q1 | 99 | 36 | 0.53 | 51% | 0.039 | 0.010 | — | entered |
| 2025Q4 | 86 | 37 | 0.00 | 57% | 0.050 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status